IL6 and neoplasm: showed that MUC1 and MUC16 inhibit Toll-like receptor (TLR)-mediated innate immune responses, reducing expression of inflammatory factors IL-6, IL-8, and TNF-α, potentially linked to tumor immune escape (75).